Tag Archives: VHI

Top 5 High Tech Stocks To Buy Right Now

SAN FRANCISCO The T in Twitter might as well stand for turmoil.

Just weeks after its chief operating officer resigned, the company this week lost two more senior executives, including its chief technology officer.

The unexpected departures pummeledthestock (TWTR), which ended the week down 11%. Some analysts believe shares, now trading in the $16 range from near $19 a week ago,could retreat to their low, below $14, as investors loseconfidence in founder Jack Dorsey. That would be a very steep decline from itsinitial trading price of $44.94in 2013 and its all-time high of $74.73.

“One C-Level departure is a red flag; two in a quarter is very disconcerting,” Mizuho Securities analyst Neil Doshi said in research note. “We view C-Level changes as red flags for any business, and two unexpected C-level changes in a short period of time could, in our opinion, create significant investment risks.”

Top 5 High Tech Stocks To Buy Right Now: Norsat International Inc.(NSAT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

Top 5 High Tech Stocks To Buy Right Now: Trevena, Inc.(TRVN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Trevena Inc (NASDAQ: TRVN) shares dropped 36 percent to $4.55 despite a positive development in Phase 3 trials. Trevena announced positive top-line results from ongoing Phase 3 trials called "APOLLO-1" and "APOLLO-2." The studies evaluated the safety of Trevena's oliceridine therapy in patients for 48 hours following bunionectomy and 24 hours following abdominoplasty.

  • [By Maxx Chatsko]

    Shares of clinical-stage biopharma Trevena (NASDAQ:TRVN) fell nearly 12% today after it reported full-year 2016 earnings. The pre-revenue company didn’t announce any surprises one way or the other. However, investors appear to be considering the near-term consequences of swelling expenses that won’t be offset by product sales anytime soon.

  • [By Paul Ausick]

    Trevena Inc. (NASDAQ: TRVN) dropped about 6.3% Thursday, to post a new 52-week low of $3.70 after closing at $3.95 on Wednesday. The stock’s 52-week high is $9.73. Volume was nearly 5 times the daily average of around 700,000 shares. The company’s pain-killing drug got mixed results in a trial result reported Tuesday.

Top 5 High Tech Stocks To Buy Right Now: OncoSec Medical Incorporated(ONCS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Top 5 High Tech Stocks To Buy Right Now: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

Top 5 High Tech Stocks To Buy Right Now: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By JPMorgan]

    We are Neutral on PCAR as the company faces the risk of both lower volume and margin pressure from declining demand in its core NA HD truck business in 2016. However, we believe PCAR should command a premium valuation due to its track record of solid execution. In addition, PCAR pays out a normal and a special dividend which, in total, should equal ~50% of net income and currently offers a yield of 4.1% (JPMe total payout of ~$2.12/share) making it potentially attractive to income-oriented investors. 

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By Jim Cramer]

    The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Machinery industry. The net income increased by 16.1% when compared to the same quarter one year prior, going from $371.40 million to $431.20 million.

     

Top 5 Medical Stocks To Buy For 2018

An alarming 36% of LGBTQ people say theyd rather spend for today than prepare for tomorrow. But what happens at the end of life and medical or nursing-assistance, either in-home or in a nursing facility is needed? The answer for queer people may be long-term care insurance (LTCI).

Why All LGBTQ People Should Consider Getting Long-Term Care Insurance – Photo by Shutterstock

LGBT Financial owner, Ryan Taylor, joined us on Queer Money to talk about long-term care insurance for queer people. LGBT Financial is based out of Salt Lake City, Utah, and operates mostly, though not exclusively, in the western United States. Taylors goal is for LGBT Financial to be a resource for the community in building financial plans where LGBTQ people can feel safe and comfortable.

Top 5 Medical Stocks To Buy For 2018: Textainer Group Holdings Limited(TGH)

Advisors’ Opinion:

  • [By Joseph Hogue]

    There is one particular shipping company of which investors are being especially fearful, to the point of hating it. I'm talking about Textainer Group Holdings (NYSE: TGH), a container leasing company with 2.6 million 20-foot equivalent containers, the largest fleet among its peers.

Top 5 Medical Stocks To Buy For 2018: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Top 5 Medical Stocks To Buy For 2018: Cheniere Energy, Inc.(LNG)

Advisors’ Opinion:

  • [By Craig Jones]

    Pete Najarian noticed that somebody bought 17,000 contracts of the July 55 calls in Cheniere Energy, Inc.(NYSE: LNG) for $0.60. He followed the trade and he is planning to hold it until expiration. The trade breaks even at $55.60 or 9.90 percent higher.

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

  • [By Manikandan Raman]

    Bays said the momentum would boost fortunes for projects like Cheniere Energy, Inc. (NYSE: LNG)’s Corpus Christi, Liquefied Natural Gas Ltd (ASX:LNG)’s Magnolia, and Tellurian Inc (NASDAQ: TELL)’s Driftwood LNG project, among others.

Top 5 Medical Stocks To Buy For 2018: BanColombia S.A.(CIB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Foreign Regional Banks: This industry declined 2 percent by 11:00 am with Bancolombia SA (ADR) (NYSE: CIB) moving down 3.7 percent. Bancolombia’s PEG ratio is 4.51.

  • [By Matt Smith]

    Bancolombia appears attractively priced
    Another Colombian company that appears under-valued is the Andean country’s largest commercial bank Bancolombia (NYSE: CIB  ) . For the year-to-date Bancolombia’s share price fell 17% because of a weak second quarter bottom-line. This decline was primarily caused by the bank’s net income plunging by 41% year-over-year because of mark-to-market losses caused by the value lost in the bank’s securities portfolio.

  • [By Javier Hasse]

    Analysts at Credit Suisse downgraded shares of Bancolombia SA (ADR) (NYSE: CIB) from Outperform to Neutral, while boosting their price target from $38 to $40.

Top 5 Medical Stocks To Buy For 2018: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

pick stock

A few days ago Mark Bern published a very informative article about Western Digital Corporation (NYSE: WDC) and raised the question if the company is an investment or a speculation? As result of different concerns regarding WDC the author ended the article with the conclusion that the stock is rather speculative. Although I wont recommend buying Western Digital at current price levels, I’m pretty pleased with my investment so far and will explain why I’m rather bullish than bearish on the stock although there might be some issues with the company. We will look at the future potential of data storage, we will look at the development of revenue and net income and end the article with an intrinsic value calculation. But we will start the discussion by looking at the most worrisome aspect the high debt levels.

The debt: Rather concerning

For many years Western Digital had almost no debt (and hence a very low D/E), but on May 12, 2016, the acquisition of SanDisk was officially completed and in order to finance the transaction WDC took on several billions in debt. On December 30, 2016, the total debt was $13,299 million. Six months earlier the total debt was about $17.5 billion and therefore WDC already managed to reduce the outstanding debt by $4.2 billion (but had to reduce the cash and cash equivalents from $8,151 million to $4,940 million). Most of the outstanding debt needs to be paid back in the years between 2020 and 2024. The D/E ratio of 1.24 can give us a first hint – that the debt levels are not extreme, but can be a burden for the company.

pick stock: Citi Trends, Inc.(CTRN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Citi Trends, Inc. (NASDAQ: CTRN) shares shot up 16 percent to $19.38 after the company posted upbeat quarterly earnings.

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 13 percent to $2.97 on strong quarterly results. Stifel Nicolaus upgraded Internap from Hold to Buy and raised the price target from $2.00 to $5.50.

pick stock: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the non-cyclical consumer goods & services shares surged 0.61 percent. Meanwhile, top gainers in the sector included Monotype Imaging Holdings Inc. (NASDAQ: TYPE), up 9 percent, and Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI), up 6 percent.

  • [By Lisa Levin]

    Shares of Monotype Imaging Holdings Inc. (NASDAQ: TYPE) were down around 12 percent to $20.90 after the company posted downbeat quarterly earnings.

pick stock: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

pick stock: Smith & Wesson Holding Corporation(SWHC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile but higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Peter Graham]

    A long term performance chart shows TASER Internationaloutperforming and all over the place while police body cam stockDigital Ally, Inc (NASDAQ: DGLY)has underperformed, Mace Security International (OTCMKTS: MACE) has been moving sideways and gun stock Sturm, Ruger & Company (NYSE: RGR) has underperformedAmerican Outdoor Brands Corp(NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC):

  • [By Chris Lange]

    Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in revenue.

pick stock: Compass Diversified Holdings(CODI)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Compass Diversified Holdings (CODI) seeks to invest in manufacturing, distribution, consumer products, and business services sectors.

    One thing I like about Compass is its strict definitions of its acquisition strategy. They have a six-step process of identifying companies to acquire that reads simply, but has lead to astounding success.

stock day trading

The S&P 500 dropped 0.4% today but that didn’t stop Western Digital (WDC) from gaining more than 3% todayand becoming the benchmark index’s hottest stock.

Reuters

Like Skyworks Solutions (SWKS) the past two days, Western Digital’s gained 3.1% to $54.94 was primarily the result of another company entirely: Intel (INTC). The chip giant raised its third-quarter revenue guidance today, which helped it become the S&P 500′s second-best performing stock after rising 3% to $37.67.

Intel cited “improving PC demand” and the “replenishment of PC supply chain inventory” for upbeat guidance, and just the possibility of better times ahead for anyone who plays in the same sand boxWestern Digital makes hard drives and flash memory chipsgot the market all excited. And don’t forget: Just last week, Western Digital’s shares surged 9.8% after the company upped its own guidance,which it credited to the acquisition of SanDisk.

stock day trading: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Biogen (BIIB)

    Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Biogen Inc. (NASDAQ: BIIB) which traded down 4.6% at $279.08. The stocks 52-week range is $223.02 to $333.65. Volume was 3.4 million versus the daily average of 1.6 million shares.

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

  • [By Brian Orelli]

    While that’s fine for clinical trials, it may make it difficult for Ionis’ drugs to compete with drugs that work as well but don’t have side effects that need to be monitored. Of course, for Spinraza, which Biogen (NASDAQ:BIIB) and Ionis recently got approved for spinal muscular atrophy, side effects aren’t an issue because there aren’t any other treatment options at the moment.

  • [By Todd Campbell]

    A new and highly anticipated study byCelgene Corp. (NASDAQ:CELG) shows that its promising multiple sclerosis drug could soon reshape the $19 billion multiple sclerosis market. On Friday, management reported that ozanimod met its primary endpoint for reducing MS relapses better than Biogen Inc.’s (NASDAQ:BIIB) Avonex, and importantly, it did so without any new safety risks.

  • [By Ben Levisohn]

    Biogen (BIIB) tumbled to the bottom of the S&P 500 today after getting cut by two analysts.

    Agence France-Presse/Getty Images

    Biogen dropped 4.7% to $278.96 at 4:19 p.m. today, while the S&P 500 declined 0.2% to 2,381.38.

    Leerinks Geoffrey Porges cited the “slower than expected ramp for Spinraza” in cutting Biogen to Market Perform from Outperform, while Morgan Stanly’s Matthew Harrison wrote that his decision to cut Biogen to Market Weight from Overweight was “not a downside call, but a timing call.”

    Biogen’s market capitalization fell to $60.2 billion today from $63.2 billion yesterday. It reported net income of $3.7 billion on sales of $10.2 billion in 2016.

    Barron’s Teresa Rivas recommended buying Biogen in December after the company released positive trial data on its Alzheimer’s drug.

stock day trading: Palo Alto Networks, Inc.(PANW)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Barracuda Networks peaking in 2015 before drifting into underperformance and then back up againwhile mid cap Fortinet Inc (NASDAQ: FTNT) and large cap Palo Alto Networks Inc (NYSE: PANW) also peaked in 2015 and bounced back a bit last year:

  • [By Lisa Levin]

    Palo Alto Networks Inc (NYSE: PANW) was down, falling around 23 percent to $116.87. Palo Alto posted upbeat Q2 earnings, but sales missed expectations. The company also issued a weak forecast for the current quarter. JP Morgan downgraded Palo Alto from Overweight to Neutral, while Baird downgraded the stock from Outperform to Neutral.

  • [By Steve Symington]

    When revenue inPalo Alto Networks Inc.’s (NYSE:PANW) latest quarter fell short of Wall Street’s expectations a few weeks ago, shares of the next-gen security specialist plummeted more than 20% in a single day. To blame, according to Palo Alto, were execution challenges that the company insists it’s “moving quickly to address.”

stock day trading: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

stock day trading: Tahoe Resources, Inc.(TAHO)

Advisors’ Opinion:

  • [By Diane Alter]

    Best Silver Stocks to Buy Now, No. 1: Tahoe Resources (NYSE: TAHO) is a Nevada-based silver miner that operates in the Americas. The company primarily produces silver, but also works with copper, gold, lead, zinc, natural gas, and petroleum. On Aug. 10, TAHO reported Q2 earnings per share of $0.19, $0.05 better than expected. Revenue rose 70.6% year over year to $228.3 million. The company recorded half-year production of 11.4 million ounces of silver and 167,168 ounces of gold. Based on operating results during the first six months of 2016, and expectations for the second half of the year, TAHO expects to achieve the top end of its 2016 guidance for silver production. New quarterly filings reveal influential hedge fund Bridgewater Associates took a new position of approximately 200,000 TAHO shares. At $13.89, TAHO is up 60.32% in 2016.

  • [By Paul Ausick]

    Tahoe Resources Inc. (NYSE: TAHO) dropped about 8.6% Friday, to post a new 52-week low of $7.27 after closing at $7.95 on Thursday. The stock’s 52-week high is $17.01. Volume was approaching double the daily average of around 2.6 million shares. The gold and silver miner reported results last night that missed profit estimates.

stock day trading: Apartment Investment and Management Company(AIV)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Scripps Networks Interactive (SNI) sunk to the bottom of the S&P 500–narrowly beating out Apartment Investment and Management (AIV)–as the parent company of the Food Network and other channels gave back a chunk of its post-elections gains.

  • [By Ben Levisohn]

    Apartment Investment & Management (AIV) tumbled today, as the weakness in real-estate investment trusts following Donald Trump’s surprise election continued today. It was the second-biggest loser in the S&P 500 today.

    Getty Images

    Shares of Apartment Investment & Management dropped 4.1% to $41.03 today, while the Real Estate SPDR Dow Jones REIT ETF (RWR) fell 1.1% to $90.03. The S&P 500 rose rose 0.8% to 2,180.39.

    In a note released yesterday, Raymond James analyst Buck Horne and team cut their price target on Apartment Investment & Management to $50 from $50, even as they maintained their Strong Buy rating. They explain why:

    Prefacing our comment qualifying the significant economic uncertainties that have arisen post Tuesdays election, we are maintaining our Strong Buy rating onApartment Investment & Management shares while slightly adjusting our target price (to $50 from $52) and net-asset-value estimate (down $1 to $48.51/share). These adjustments are solely to reflect slightly more conservatism in our cap rate assumptions following the post-election interest rate shifts. We continue to find Apartment Investment & Managements risk/reward profile compelling in this environment as its diversified class B-priced portfolio should prove more resilient to supply pressures and benefit from the growing shortage of affordable workforce housing. In an inflationary environment with potentially declining housing affordability, we are particularly attracted to Aimcos price points, demographics, and balance sheet full of long-dated, non-recourse, fixed rate leverage.

    Apartment Investment & Management reported net income of $67 million on sales of $978 million in 2015.

stock day trading: Live Ventures Incorporated(LIVE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested going long onsmall cap real-time deal engine stock Live Ventures Inc (NASDAQ:LIVE):

Top 10 Medical Stocks To Invest In 2018

On Monday, our Elite Opportunity Pronewsletter suggested going long on small cap healthcare products and services stock Natus Medical (NASDAQ: BABY):

Furthermore, Natus Medical Management has managed to beat earnings and revenue estimates for four out of the last five quarters, providing investors with confidence in their ability to manage the Street’s expectations. Assuming the Company continues its current growth trajectory, we expect at least 22% bottom line growth from this year to next.

Technically, shares of BABY have pulled back following a tremendous run that began in late 2013, which didn’t stall until late 2015. Since then, shares have been range bound off its highs of just over $51 per share. Provided below are both a daily and a weekly chart showing you not only what type of run the stock is capable of making once it finds its footing, but also the wide range its traded within for a little over a year now. As you can see, volume in the stock has once again started to pick up steam, along with bullish price action in anticipation of another sharp move higher.

Top 10 Medical Stocks To Invest In 2018: National Oilwell Varco, Inc.(NOV)

Advisors’ Opinion:

  • [By Tony Daltorio]

    But the best investment in this sector, according to Moors, is National Oilwell Varco Inc. (NYSE: NOV).

    He calls it the “one company that stands to benefit most directly from what is happening in the equipment sector.”

  • [By Shauna O’Brien]

    Jefferies reported on Monday that it has lifted its price target on National-Oilwell Varco, Inc. (NOV).

    The firm has reaffirmed a “Buy” rating on NOV, and has raised the company’s price target from $84 to $91. This price target suggests a 14% increase from the stock’s current price of $78.24.

    Analyst Brad Handler noted that NOV’s weak margin will likely rebound in 2014 and the chances of a dividend increase are high.

    Looking forward, the firm has lifted its order estimates for FY2013 from $10.8 billion to $11.3 billion. FY2014 earnings estimates have been raised from $6.40 to $6.50 per share and FY2015 estimates have been increased from $7.65 to $7.95 per share.

    National-Oilwell Varco shares were up 76 cents, or 0.97% during pre-market trading Monday. The stock is up 14% YTD.

  • [By Lauren Pollock]

    Among the companies with shares expected to actively trade in Tuesday’s session are Applied Materials Inc.(AMAT), Red Hat Inc.(RHT) and National Oilwell Varco Inc.(NOV)

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggestedgoing long on large cap oilfield equipment manufacturer and technology stock National-Oilwell Varco, Inc (NYSE: NOV):

Top 10 Medical Stocks To Invest In 2018: General Growth Properties, Inc.(GGP)

Advisors’ Opinion:

  • [By Paul Ausick]

    GGP Inc. (NYSE: GGP) posted a new 52-week low of $22.12 on Wednesday, down about 2.2% compared with Tuesday’s closing price of $22.61. The stock’s 52-week high is $32.10. Volume of around 4 million shares was about 20% below the daily average of around 5 million shares. The retail REIT had no specific news.

  • [By Paul Ausick]

    Rounding out the top 10 in terms of total installed solar PV capacity are Prologis Inc. (NYSE: PLD) with 108 MWs of installed capacity, Apple Inc.(NASDAQ: AAPL with 94 MWs, Costco Wholesale Corp. (NASDAQ: COST) with 51 MWs, Kohl’s Corp. (NYSE: KSS) with 50 MWs, IKEA with 44 MWs, Macy’s Incl. (NYSE: M) with 39 MWs, General Growth Properties Inc. (NYSE: GGP) with 30 MWs, and tied with 23 MWs, Hartz Mountain and Bed, Bath and Beyond Inc. (NASDAQ: BBBY).

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was GGP Inc. (NYSE: GGP) which rose about 17% to $22.21. The stocks 52-week range is $18.83 to $27.10. Volume was about51 million compared to its average volume of 5.7 million.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was GGP Inc. (NYSE: GGP) which jumped about 4.7% to $22.62. The stocks 52-week range is $21.05 to $32.10. Volume was roughly 14.5 million which is above the daily average of around 5.3 million shares.

  • [By Paul Ausick]

    GGP Inc. (NYSE: GGP) posted a new 52-week low of $21.05 on Monday, down 1.5% compared with Friday’s closing price of $21.37. The stock’s 52-week high is $32.10. Volume of around 13 million shares was more than double the daily average of around 5.3 million shares. The company slipped after announcing earnings this morning but is on a pace to close the day up more than 4.5%.

Top 10 Medical Stocks To Invest In 2018: TD Ameritrade Holding Corporation(AMTD)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    TD Ameritrade (AMTD) is very strong today for one reason — it’s a bull market stock — that directly benefits from a rising stock market, explains growth stock expert Mike Cintolo, editor of Cabot Top Ten Trader.

  • [By Chris Dier-Scalise]

    That's the goal of TD Ameritrade Holding Corp.'s (NASDAQ: AMTD) Investor Movement Index, or IMX. The index tracks the activity of TD Ameritrade investors to measures how they are positioned in the markets.

  • [By Dan Caplinger]

    Yet not all brokers decided to match Fidelity. TD Ameritrade (NASDAQ:AMTD) made a reduction in its commission, but by moving from $9.99 to $6.95, the company didn’t close the competitive gap entirely. In justifying that, CEO Tim Hockey said that TD Ameritrade’s clients “have told us time and again that value is delivered via rich experiences that prioritize flexibility and client choice, coupled with a simple, straightforward price.” The company pointed to its trading platforms, tools, product selection, and customer support as marks of distinction for TD Ameritrade over its peers.

Top 10 Medical Stocks To Invest In 2018: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) soared to the top of the S&P 500 today after its audit committee found no need to restate the company’s financials.

    Agence France-Presse/Getty Images

    Alexion Pharmaceuticalsgained 9.5% to $139.18 today, while the S&P 500 dipped 0.1% to 2,269.00.

    Morgan Stanley’sMatthew Harrison and team argue that the audit committees report is “lifting a cloud” over Alexion, but they still have their concerns:

    Without significant fireworks mgt. has filed the 10-Q lifting a cloud around the details on the potential wrong doing and its impact. While the “pull-in” sales had less than a 1% impact and do not appear pervasive in use as evidenced by the limited amount outside of 4Q15, we do wonder how the increased scrutiny will impact the selling organization and the potential increased conservatism among personnel going forward. We look forward to 2017 guidance and updates to MG filing and 1210 enrollment at the 4Q16 call.

    Alexion’s market capitalization rose to $31.2 billion today from $28.5 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By Paul Ausick]

    Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) posted a new 52-week low of $98.63 on Wednesday, down about 5.7% compared with Tuesday’s closing price of $04.64. The stock’s 52-week high is $157.02. Volume totaled about 8.5 million shares, around 4 times the daily average of about 3 million. The company announced several executive changes on Tuesday and the fallout has continued.

  • [By David Sterman]

    Growth-oriented investors should also check out Alexion Pharmaceuticals (Nasdaq: ALXN(link is external)), which falls through the cracks between the massive well-established biotechs, and the small-cap biotechs that are still pre-revenue.

    Alexion targets rare and severe diseases, and has built a broad platform of drugs to treat them. Sales growth has never been less than 37% at any point in the past eight years, and 20% to 25% growth appears locked in over coming years as well. Analysts at UBS, who see 30% upside to their $202 price target, believe that a healthy drug pipeline provides multiple catalysts this year in the form of clinical trial updates. They suggest that shares would be worth $230 in a buyout scenario. 

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) sunk to the bottom of the S&P 500 today, a drop that is being attributed to revelations on Wednesday night that it had to delay its 10-Q because of a whistle blower investigation into its sales practices.

    Getty Images

    Shares of Alexion Pharmaceuticals tumbled 10% to $$113.62 today, while the S&P 500 dipped 0.1% to 2,164.45.

    After speaking with Alexion CEO Vika Sinha, Citigroup’s Robyn Karnauskas and Mohit Bansal see a buying opportunity. “As we highlighted in our previous note, we cannot envision anything that changes numbers fundamentally and see this weakness as buying opportunity,” they write. They also write that they looked at the companies past financials and saw no red flags, while noting that Soliris, the drug that is causing all the problems, “is sold on named patient basis, therefore, chances of fake sales are very minimal.”

    Alexion Pharmaceuticals market capitalization fell to $25.4 billion today from $28.5 billion yesterday.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)

Top 10 Medical Stocks To Invest In 2018: LKQ Corporation(LKQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

Top 10 Medical Stocks To Invest In 2018: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

Top 10 Medical Stocks To Invest In 2018: Cummins Inc.(CMI)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Cummins Inc. (NYSE: CMI) which traded down about 5% at $159.44. The stocks 52-week range is $134.06 to $181.79. Volume was over 3.5 million versus the daily average of 1.2 million shares.

  • [By Reuben Gregg Brewer]

    Making mining equipment has been a horrible business over the last few years. The industry has been hard-hit by the spending cutbacks at mine sites around the world. For example, BHP Billiton Limited trimmed its capital exploration expenditures by roughly 70% between fiscal 2013 and 2016. No wonder Caterpillar Inc. (NYSE:CAT), Komatsu Ltd. (NASDAQOTH:KMTUY), and Cummins Inc. (NYSE:CMI) have been hurting. Only that looks like it’s starting to change, which means this trio could be at the top of a list of mining equipment companies to buy in 2017.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By Reuben Gregg Brewer]

    Ever walk past a construction site? It’s hard not to be enthralled by all the heavy construction machinery moving things around. With the world’s developing economies still building at a relatively fast pace and developing economies, like the United States, in desperate need of upgrading their aging infrastructure, the companies behind that construction machinery could be just as exciting as a construction site in the years ahead. Which is why Caterpillar Inc. (NYSE:CAT), Cummins Inc. (NYSE:CMI), and Terex Corporation (NYSE:TEX) are three of the top construction machinery stocks to look at right now.

  • [By WWW.THESTREET.COM]

    There are lots of stories like that out there these days. People were perplexed about the Illinois Tool Works (ITW) and Cummins Engine (CMI) and Caterpillar (CAT) quarters, but they turned out to be classic buying opportunities after years of being sell opportunities if the stocks had run. I can’t explain to you how amazing that is. Here are three stocks that have spent months and months in purgatory when they have missed or guided down or slashed forecasts. Now they are up gigantically.

Top 10 Medical Stocks To Invest In 2018: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

Top 10 Medical Stocks To Invest In 2018: NVIDIA Corporation(NVDA)

Advisors’ Opinion:

  • [By Rick Munarriz]

    One wouldn’t expect investors to find hot stock ideas in the cutthroat realm of video chips, but that’s exactly where two of the hottest stocks in recent years reside.NVIDIA(NASDAQ:NVDA) was the S&P 500’s biggest gainer last year, soaring 224% as themaker of graphic cards broadens its reach for everything from artificial intelligence to virtual reality.

  • [By Sreekanth Anasa]

    Shares of Sunnyvale, California-based, Advanced Micro Devices, Inc. (NASDAQ:AMD)weredown by more than 3% in yesterday’s trading session (April 4th) and also dropped further by around 1% in the initial after-market hours. This could have been partly caused by thedowngrading of NVIDIA (NASDAQ:NVDA) stock byPacific Crest analysts. Their research finds that desktop GPU market has reached saturation levels which could hurt NVIDIA. AMD has its flagship GPU launch slated for this quarter and the arguments of the Pacific Crest analysts might not have gone down well with some investors. AMD stock did not deliver a decent performance in the last month(March) by its standards but now, with another important product launch in Ryzen 5 on April 11, the question arises, will AMD stock see a rally like the one which preceded the Ryzen 7 launch? Of late, AMD stock has some positives going for it. To add to that, some recent news about Ryzen 5 CPUs suggest the Sunnyvale-based chipmaker could gain big going ahead. Let’s take a closer look.

  • [By Peter Graham]

    A long term performance chart shows shares of AmbarellaInc peaking in mid 2015before falling offto move within a range for the past two years while the performance oflarge capNVIDIA Corporation (NASDAQ: NVDA) has surged and small cap end customerGoPro Inc is still underperforming:

Top 10 Medical Stocks To Invest In 2018: Christopher & Banks Corporation(CBK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Christopher & Banks Corporation (NYSE: CBK) got a boost, shooting up 24 percent to $1.50 after the company reported strong preliminary revenue for the third quarter.

  • [By Lisa Levin]

    Christopher & Banks Corporation (NYSE: CBK) shares were also up, gaining 40 percent to $2.64. Christopher & Banks reported a Q4 loss of $0.24 per share on revenue of $94.6 million. The company projects Q1 revenue of $93 million to $98 million.

top 10 penny stocks

By Irina Slav

The solar sector is reeling from confusion, and stock prices are reeling right along with it. The time it has taken investors and traders to wrap their heads around Trump’s industry tariffs and the pyrrhic victory of two solar companies in a case against cheap Chinese imports has seen stocks rally in a big way, and then fall just as hard.

When the International Trade Court ruled in favor of plaintiffs Suniva and SolarWorld in their case against cheap Chinese solar module and cell imports, reactions were polarized: the U.S. solar industry was outraged-as it had been for most of the duration of the court investigation-and investors, apparently, were extremely upbeat for the future of this same outraged industry, sending solar stocks sky-high.

The rally did not last long, though. While investors’ immediate reaction to the court ruling was of the unsurprising knee-jerk variety, reality started to set in over the last few days and solar stocks took a nosedive as sharp as the rally they enjoyed last week. Just what the solar companies needed after the ruling that threatened their chances of survival.

top 10 penny stocks: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

top 10 penny stocks: Aethlon Medical, Inc.(AEMD)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

top 10 penny stocks: RadiSys Corporation(RSYS)

Advisors’ Opinion:

  • [By Lisa Levin]

    RadiSys Corporation (NASDAQ: RSYS) was down, falling around 18 percent to $2.95 after the company lowered its sales forecast for the second quarter. The company now expects Q2 sales of $35 million, versus earlier outlook of $41 million to $47 million.

  • [By Lisa Levin]

    RadiSys Corporation (NASDAQ: RSYS) was down, falling around 18 percent to $2.97 after the company lowered its sales forecast for the second quarter. The company now expects Q2 sales of $35 million, versus earlier outlook of $41 million to $47 million.

top 10 penny stocks: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Ciena Corp. (NYSE: CIEN) will report its most recent quarterly results Thursday morning. The consensus estimates call for EPS of $0.49 and $726.84 million in revenue. Shares closed at $23.87 on Friday, in a 52-week range of $18.94 to $27.98. The consensus price target is $30.77.

  • [By Billy Duberstein]

    The reasons for the price drop could be a number of things, including increased competition, notably from Ciena(NYSE: CIEN). This was noted by CEO Thomas Fallon who, in the recent conference call, noted competitors may be trying to “buy” market share:

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, with the Dow Jones Industrials falling while the Nasdaq Composite posted modest gains. Parts of the market reacted differently to conflicting news items, which included both poor performance in the energy market and signs of promise for the economy more broadly. Despite the conflict among industry sectors, some stocks got hit particularly hard, and Rite Aid (NYSE:RAD), Ciena (NYSE:CIEN), and Express (NYSE:EXPR) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

trade penny stocks

You can buy Spanish stocks today at 1998 prices…   That's crazy, right? It's rare to see an asset trading for the same price it was 20 years ago. But that's the reality in Spanish stocks right now.   However, this situation won't last for long… Spanish stocks just broke out to a 52-week high. And history says they should continue higher as a result.   Let me explain…   The iShares MSCI Spain Capped Fund (EWP) broke out to a new 52-week high earlier this month. It trades around $30 right now. But here's the crazy thing…   That's the same price it traded for in late 1998… nearly 20 years ago.   Spanish stocks – as measured by EWP – have gone nowhere for 20 years. It's hard to believe, but it's true.   Not surprisingly, Spanish stocks are a better value today than they were in 1998…

trade penny stocks: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.

  • [By Lisa Levin]

    Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.

trade penny stocks: Nuveen Select Tax Free Income Portfolio(NXP)

Advisors’ Opinion:

  • [By Eric Volkman]

    Income investors might be wary of Qualcomm, as the company loves to spend its money — at times, its dividend payouts and share buybacks have exceeded free cash flow. Compounding that matter, the company should soon close the door on its acquisition of European peer NXP Semiconductor (NYSE:NXP), a deal with an estimated enterprise value of $47 billion.

trade penny stocks: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Anavex Life Sciences (OTCQX:AVXL) is down ~40% since Amit Ghate said it would trade substantially lower in an interview with the PRO Weekly Digest in June (see his update comment).

  • [By WWW.MONEYSHOW.COM]

    The lead drug from Anavex Life Sciences (AVXL) — called Anavex 2-73 — has just reported very promising phase 2a results in Alzheimer’s patients at the annual CTAD conference.

trade penny stocks: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

trade penny stocks: Impax Laboratories, Inc.(IPXL)

Advisors’ Opinion:

  • [By Keith Speights]

    Impax Laboratories (NASDAQ: IPXL  ) could be watching more closely than Sanofi. The two companies reached a deal last year that allows Impax to begin marketing a generic version of Renvela in 2014. If approved, Zerenex could take away some of the profits that Impax expected to gain.

  • [By Lisa Levin]

    Shares of Impax Laboratories Inc (NASDAQ: IPXL) were down around 29 percent to $10.12. Impax Labs reported Q4 adjusted earnings of $0.16 per share on revenue of $198.4 million.